Companies: 10,795·Total market cap: $144.5T
Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILDNASDAQHealthcare● Active
$129.16
$-0.02(-0.02%)
Market Cap$160.4B
P/E Ratio
52W High$157.29
52W Low$104.46
Overview

Gilead Sciences, Inc. (GILD) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

gild · stock forecast · 58 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 58 Wall Street analysts in the past 3 months

SellBuy

Buy

58 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
39
Hold
18
Sell
1
Strong Sell
0
Total: 58 · Buy rate: 67.2%

12-Month Price Target

High

$180

Consensus

$160

+23.5% upside

Low

$122

Median: $162.5 · Last Close: $129.16

The Gilead Sciences, Inc. (GILD) analyst consensus is Buy, based on ratings from 58 Wall Street analysts over the past 3 months. The average 12-month GILD price target is $159.56, representing +23.5% upside from the current price of $129.16.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $160 (23.5%)

Consensus Target

$159.56

23.5% upside

High Target

$180

39.4%

Low Target

$122

-5.5%

Current Price

$129.16

as of today

Based on analyst price targets, the GILD stock price prediction for the next 12 months ranges from $122 to $180. The consensus GILD price forecast of $159.56 implies 23.5% upside from the current price of $129.16.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$127.451.32%

1-day model range: $127.12–$127.79. Peak: $127.79 (-1.32%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$161+24.7%
2028$187+44.7%
2029$206+59.8%
2030$220+70.6%
2031+78.1%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

14%7%79%
2Buy
1Neutral
11Sell
RSI (14)48.9Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · GILD · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$129.20SELL
MA 10$131.84SELL
MA 20$131.71SELL
MA 50$134.18SELL
MA 100$138.54SELL
MA 200$128.92BUY
Current $GILD · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$129.77SELL
EMA 10$130.69SELL
EMA 20$131.63SELL
EMA 50$133.87SELL
EMA 100$133.93SELL
EMA 200$128.81BUY
Current $GILD · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Maxim Group2026-05-20
Upgrade ↑
HoldBuy
RBC Capital2026-05-08
Maintains
Sector PerformSector Perform
Truist Securities2026-05-08
Maintains
BuyBuy
Citigroup2026-04-13
Maintains
BuyBuy
Morgan Stanley2026-04-10
Maintains
OverweightOverweight
Needham2026-02-23
Maintains
BuyBuy
Truist Securities2026-02-11
Maintains
BuyBuy
Wells Fargo2026-02-11
Maintains
OverweightOverweight
RBC Capital2026-02-11
Maintains
Sector PerformSector Perform
Needham2026-02-11
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Gilead Sciences, Inc. (GILD) stock. Of the recent 482 rating actions, 58 were upgrades and 53 were downgrades. 58 analysts currently cover GILD.

Analyst Recommendation Trends

Buy ratings22
Hold ratings01↑ +1
Sell ratings00

GILD analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$30.5B

↓ 11.3% YoY

Revenue Next Year

$32.4B

↑ 6.4% YoY

EPS This Year

$-0.06

EPS Next Year

$9.65

↓ 16229.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast GILD EPS of $-0.06 for the current fiscal year, based on estimates from 15 analysts. The GILD revenue forecast is $30.5B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The GILD stock forecast is supported by two independent data sources: analyst consensus ratings from 58 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus GILD price target is $159.56 (+23.5% upside), with an analyst consensus of Buy.

The GILD short-term stock prediction for tomorrow is $127.45 (-1.32%). The GILD stock price prediction for 2027 estimates an average of $161. The GILD stock prediction for 2030 projects a range of $214–$227.

Gilead Sciences, Inc. trades on NASDAQ under the ticker GILD. The GILD stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

GILD forecast · 8 questions

According to 58 Wall Street analysts, the average 12-month GILD price target is $159.56, with a high forecast of $180.00 and a low of $122.00. The median price target is shown in the chart above when available. This implies +23.5% potential upside from the current price of $129.16.

GILD price targetWhat is GILD price targetGILD analyst price targetGILD 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.